Cambrex Corporation

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our custom development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. Cambrex has extensive experience developing process to manufacture drug substances for clients use in toxicology studies, clinical studies and commercial supply. Our broad range of services include route selection, process and analytical development, process optimization and scale-up, safety assessments and product formulation. Our R&D and cGMP manufacturing facilities in the US and Europe, an excellent regulatory compliance record, and a strong expertise in various chemical technologies. We are committed to operating our facilities with the highest standards for regulatory, environmental, health, safety, and security guidelines. We actively incorporate Lean Six Sigma to consistently deliver efficient, high quality, and cost competitive products with less time to market for our clients. Our focus and goal is to provide solutions to large and small pharmaceutical companies with both established and emerging drug pipelines.